Re: “Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma” by Kim et al. ( Thyroid 2019;29:963–970. DOI: 10.1089/thy.2018.0541)
Restricted accessResearch articleFirst published online March, 2020
Re: “Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma” by Kim et al. ( Thyroid 2019;29:963–970. DOI: 10.1089/thy.2018.0541)
KimHI, HyeonJ, ParkSY, AhnHS, KimK, HanJM, BaeJC, ShinJH, KimJS, KimSW, ChungJH, KimTH, OhYL. 2019. Impact of extranodal extension on risk stratification in papillary thyroid carcinoma. Thyroid, 29:963–970.
2.
HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardDL, TuttleRM, WartofskyL. 2016. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26:1–133.
3.
RoweME, OzbekU, MachadoRA, YueLE, Hernandez-PreraJC, ValentinoA, QaziM, Brandwein-WeberM, LiuX, WenigBM, UrkenML. 2018. The prevalence of extranodal extension in papillary thyroid cancer based on the size of the metastatic node: adverse histologic features are not limited to larger lymph nodes. Endocr Pathol, 29:80–85.
